Literature DB >> 27071939

Clearance of extractables and leachables from single-use technologies via ultrafiltration/diafiltration operations.

Nicholas Magarian1, Kate Lee1, Kunal Nagpal1, Ken Skidmore1, Ekta Mahajan1.   

Abstract

Quantifying the clearance of extractables and leachables (E/L) throughout ultrafiltration/diafiltration (UFDF) operations allows for greater flexibility in the implementation of single-use technologies in steps upstream of the UFDF process. A proof-of-concept study was completed in which the clearance of 7 E/L from single-use technologies (trimethylsilanol, hexanoic acid, butyrolactone, t-butyl alcohol, caprolactam, acetonitrile, and benzyl alcohol) in four representative proteins were measured and monitored during the UFDF process using quantitative NMR. This study demonstrated that the defined E/L spiked into a variety of protein solutions can be cleared to <1 ppm by 9 diavolumes from a maximum initial load concentration of 1,000 ppm. However, in some cases a rebound effect was observed in the recovered pool to >1 ppm, which is explained in detail. The overall clearance trend observed for both buffer control and protein-containing solutions resembled the ideal clearance trend where no apparent interactions were observed between E/L with the protein, UFDF system, or with other defined E/L which may be present in the system. Additionally, the UFDF system is capable of clearing these potential E/L from single-use technologies below 1 ppm irrespective of initial concentrations in the load (1,000 or 100 ppm), independently from the type of protein. In general, mass recoveries were within ±15% of each spiked compound in protein solutions and their respective buffer controls, suggesting spiked E/L do not interact strongly with protein. By demonstrating the product independent clearance trends of the spiked E/L across UFDF, these results will contribute to the simplification of the E/L toxicology assessment and allow modular manufacturing approach for single-use technologies in biopharmaceutical manufacturing.
© 2016 American Institute of Chemical Engineers Biotechnol. Prog., 32:718-724, 2016. © 2016 American Institute of Chemical Engineers.

Entities:  

Keywords:  NMR; clearance; extractables and leachables; single-use; ultrafiltration/diafiltration

Mesh:

Substances:

Year:  2016        PMID: 27071939     DOI: 10.1002/btpr.2277

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  3 in total

1.  X-ray sterilization of biopharmaceutical manufacturing equipment-Extractables profile of a film material and copolyester Tritan™ compared to gamma irradiation.

Authors:  Roberto Menzel; Samuel Dorey; Tanja Maier; Ina Pahl; Armin Hauk
Journal:  Biotechnol Prog       Date:  2021-10-03

2.  Comprehensive Assessment of Protein and Excipient Stability in Biopharmaceutical Formulations Using 1H NMR Spectroscopy.

Authors:  Jack E Bramham; Adrian Podmore; Stephanie A Davies; Alexander P Golovanov
Journal:  ACS Pharmacol Transl Sci       Date:  2020-12-16

3.  Safety risk management for low molecular weight process-related impurities in monoclonal antibody therapeutics: Categorization, risk assessment, testing strategy, and process development with leveraging clearance potential.

Authors:  Haibin Luo; Yuling Li; David Robbins; Sheau-Chiann Wang; Guoling Xi; Matthew Cox; Simone M Nicholson; Chenghong Wei; Timothy M Pabst; William K Wang
Journal:  Biotechnol Prog       Date:  2021-01-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.